FCF Healthcare & Life Sciences Venture Capital Monitor - Europe - 03/2024 published - FCF Fox Corporate Finance GmbH

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 03/2024”. The Monitor is a monthly published overview of venture capital trends in the European Healthcare & Life Sciences sector.

As of the end of March 2024 we identify the following current VC trends in Europe:

• Total Healthcare & Life Sciences funding reached EUR 1,962m
• Biotech received 60% of the total investment volume (EUR 1,172m) with oncology being the leading indication (53%)
• In March Tubulis (Germany) secures the highest transaction volume with EUR 128m, followed by Nouscom (Switzerland) with EUR 76m and Mission Therapeutics (United Kingdom) with EUR 51m
• M&G Investments (United Kingdom) is the most active investor (by deal volume), followed by Patient Square Capital (United States) and Rock Springs Capital (United States)

To access the full report, please click here.